CCLD CCLD
Company Profile ↓Company Overview
CCLD (CCLD) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 18.1%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 17.9%.
Revenue has grown at a 22.6% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $120.50M (+8.7% YoY); net profit $10.80M.
- Trailing 12 Months Year-on-year growth — revenue +8.7%, earnings +37.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 22.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 22.58% |
| 1 Year: | 8.72% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 37.54% |
Stock Price Performance
| 1 Year: | +6.72% |
| 6 Months: | +0.40% |
| 3 Months: | -13.31% |
| 1 Month: | +18.69% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)61.96 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 22.6% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 33.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 7.78M | 7.51M | 8.31M | 8.68M | 17.04M | 15.08M | 16.75M | 16.85M | 21.87M | 19.58M | 31.64M | 29.77M | 34.06M | 38.30M | 35.34M | 37.23M | 33.72M | 30.00M | 29.36M | 29.28M | 25.96M | 28.09M | 28.55M | 27.63M | 27.38M | 31.07M | 31.27M |
| Operating Income | -157.99K | -216.69K | -321.93K | -388.60K | -2.40M | -1.17M | -1.50M | -1.28M | -1.80M | -1.07M | -1.27M | -2.41M | -1.38M | -274.96K | 39.12K | 72.45K | -1.78M | -238.00K | -1.23M | 669.42K | -2.84M | -4.61M | -1.24M | -1.68M | -106.00K | 1.43M | 1.22M | 2.75M | 1.69M | -223.00K | -1.29M | -1.97M | 129.00K | 2.27M | 3.27M | 2.02M | 3.00M | 3.21M | 1.00M |
| Net Income | -87.46K | -138.02K | -383.67K | -289.40K | -2.84M | -1.17M | -1.49M | -1.23M | -1.98M | -1.29M | -1.49M | -2.71M | -1.69M | -980.12K | 75.04K | 195.28K | -1.83M | -295.69K | -770.97K | -137.54K | -2.50M | -4.79M | -1.67M | -1.96M | -227.00K | 1.50M | 1.14M | 2.74M | 1.06M | -401.00K | -1.83M | -2.75M | -241.00K | 1.67M | 3.12M | 1.95M | 2.90M | 3.06M | 922.00K |
| Diluted EPS | -0.02 | -0.03 | -0.08 | -0.06 | -0.34 | -0.12 | -0.15 | -0.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 | -0.18 | -0.28 | -0.37 | -0.42 | -0.10 | -0.14 | -0.04 | -0.04 | 0.04 | 0.04 | -0.01 |
| R&D Expense | 98.97K | 94.54K | 116.43K | 126.11K | 154.06K | 164.93K | 165.25K | 159.14K | 190.79K | 209.40K | 174.88K | 280.85K | 313.40K | 249.04K | 255.88K | 248.92K | 263.72K | 254.66K | 218.41K | 175.76K | 2.33M | 2.15M | 2.37M | 2.03M | 1.81M | 488.00K | 985.00K | 1.10M | 1.17M | 1.08M | 1.19M | 1.26M | 913.00K | 1.05M | 800.00K | 1.24M | 1.02M | 1.58M | 2.42M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.47M | 18.30M | 23.08M | 24.49M | 31.81M | 50.55M | 64.44M | 105.12M | 139.60M | 138.83M | 117.06M | 110.84M | 120.50M |
| Operating Income | -127.52K | -4.04M | -4.46M | -7.90M | -4.52M | -2.54M | 67.00K | -8.27M | 3.53M | 6.61M | -47.12M | 9.12M | 11.34M |
| Net Income | -178.00K | -4.51M | -4.69M | -8.80M | -5.57M | -2.14M | -872.00K | -8.81M | 2.84M | 5.43M | -48.67M | 7.85M | 10.80M |
| Diluted EPS | -0.03 | -0.64 | - | - | - | - | - | - | - | -0.67 | -4.11 | -0.28 | 0.10 |
| R&D Expense | 386.11K | 531.68K | 659.18K | 902.19K | 1.08M | 1.03M | 871.00K | 9.31M | 4.41M | 4.40M | 4.74M | 3.78M | 6.38M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Jan 2018 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 5.77M | 23.11M | 26.68M | 28.32M | 25.53M | - | 47.62M | 56.40M | 138.00M | 140.85M | 136.17M | 77.83M | 71.61M | 87.60M |
| Total Equity | 406.08K | 118.50K | 14.32M | 14.89M | 7.07M | 20.25M | 21.69M | 38.87M | 42.84M | 101.25M | 97.93M | 101.69M | 41.72M | 49.77M | 59.51M |
| Cash & Equivalents | 268.32K | 497.94K | 1.05M | 8.04M | 3.48M | 4.36M | - | 14.47M | 19.99M | 20.93M | 9.34M | 12.30M | - | - | - |
| Long Term Debt | - | - | 0 | 4.84M | 4.03M | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | 5.65M | 8.79M | 11.78M | 21.26M | 5.28M | - | 8.75M | 13.56M | 36.75M | 42.92M | 34.48M | 36.11M | 21.84M | 28.09M |
| Current Liabilities | - | 3.41M | 8.14M | 5.76M | 15.86M | 4.32M | - | 8.16M | 11.18M | 29.02M | 29.56M | 22.40M | 23.30M | 19.58M | 24.42M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.88M | -889.34K | 281.64K | 6.81M | 7.62M | -892.00K | - | 21.15M | 15.46M | 20.64M | 28.56M |
| Investing Cash Flow | - | -602.42K | -3.83M | -902.21K | -13.63M | -4.16M | -31.47M | - | -11.77M | -11.61M | -7.41M | -24.54M |
| Financing Cash Flow | - | 9.50M | 148.81K | 1.84M | 17.66M | 1.42M | 33.42M | - | -7.65M | -13.29M | -11.26M | -5.61M |
| Capital Expenditure | - | - | - | - | - | -2.02M | -2.59M | - | -11.77M | -11.61M | -7.41M | -8.03M |
| Free Cash Flow | - | - | - | - | - | 5.60M | -3.48M | - | 9.38M | 3.85M | 13.24M | 20.53M |
| Net Change in Cash | - | - | - | - | - | - | - | - | 1.73M | -9.44M | 1.98M | -1.58M |
| Share Buybacks | 0 | 122.03K | 546.14K | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | -1.2% | -22.1% | -19.3% | -32.3% | -14.2% | -5.0% | 0.1% | -7.9% | 2.5% | 4.8% | -40.2% | 8.2% | 9.4% |
| Net Margin % | -1.7% | -24.6% | -20.3% | -35.9% | -17.5% | -4.2% | -1.4% | -8.4% | 2.0% | 3.9% | -41.6% | 7.1% | 9.0% |
| ROE % | -150.2% | -31.5% | -31.5% | -124.5% | -27.5% | -5.5% | -2.0% | -8.7% | 2.9% | 5.3% | -116.7% | 15.8% | 18.1% |
| ROCE % | -5.4% | -27.0% | -21.3% | -63.4% | -21.3% | -6.4% | 0.1% | -7.6% | 3.2% | 5.8% | -86.4% | 17.5% | 18.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CCLD
CareCloud (CCLD) director reports 25,000 RSU grant and 6,250-share vesting - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNM21qakhhdTlmV1RJOU0wSTBKVFVJUGJpcHl0bmN6MnVCOVBDamZ2TzZlYWFIcmFUN0llcjdJZW9JenA3OWg3d1M0SGdEank1U1VnT3lMQzU5TGFBTXFIa2t6T2xHRWxDMzczVzFmSXlNMWJ0NWlIRU1IMFVudzg5MWRBenB3SVJuNThoZm…
Is CareCloud (CCLD) Stock Undervalued Right Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPRnE2VWtMVlF5di1FNjdZMDItVGxWR1Q2TUV5UUNKeE1jWElKbHNvaFZCSlotM0NZc3NDZnREQW5USkdEV0xwMG5obHZqaGlyVDVueE1fU3RBT2F5TGhPZl9fOUMxUEV5NXZIRElOWXItcEdEbTI1QWktTEdEVlpzbVlIOE91UGVOUnpfMH…
CCLD|CareCloud Inc|Price:2.530|Chg%:+0.090 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9YMnVLMzRMS0lBSndsRFg3RUEyTFFKTk9ITGVzSWd2YURfUWJVd1hxWnVVLTRzT1lCbmlObm91SnNaV2VXclRJNzM0R1hHaEhLTlBCNzk3eTQ0ZXZ6ZTB5UkRUMmZkbE1pS1BsZzdR?oc=5" target="_blank">CCLD|CareCloud Inc|…
CCLD - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE9uMTR1VWtfN1hDRW85YmtPcnpNOEVmRGJSWFA1aG5UeVZaOExBck1COWxVLVRUWDZqTDNsa0JjVWFnNFh5dEE?oc=5" target="_blank">CCLD</a> <font color="#6f6f6f">Finviz</font>…
Should Value Investors Buy CareCloud (CCLD) Stock? - qz.com
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9YUVZjSTZvcW5PRTFPVkhXZm1VaGZjNXZiM3lBbEZSY2w0Y1IzSDhOV190V3Mycm4xM0ZpQ2VTU0QwV1VoYUZHSTZFdU53aW9xWVRVWUJzQmJneUxFa0plOFNwbTQ2VFpocVpXVzdlSQ?oc=5" target="_blank">Should Value Inve…
The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOYjk4WFRBaHh1d0Z6ZXNfYklBX1g5MVlTU19DQ2g5bWpHcDNlWkdXZGJVVFgxNzZzam85RWNJR0JDLUludFh1YjNpZ09vU1B3VTljT3hDamRrT1Q0YUlfTjNFQ1FiMFV1bWxNbEVqdUwwbS15d3RrOHdfWTZkRHkxYi1lbnhXR1ZuZ2ljSi…
CCLD — Frequently Asked Questions
What is the current share price of CCLD?
As of 2026-08-05 17:25 PDT, CCLD trades at $2.54 on NASDAQ/NYSE. Its 52-week range is $2.08 to $3.84.
What is the P/E ratio of CCLD?
CCLD trades at a trailing price-to-earnings (P/E) ratio of 25.40.
What is the return on equity (ROE) of CCLD?
CCLD has a return on equity (ROE) of 18.15%. Its return on capital employed (ROCE) is 17.95%.
Is CCLD a good stock to buy?
This page provides a data-driven analysis of CCLD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.